Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Abbott Laboratories Named in Class Action Lawsuit.


NEW YORK--(BUSINESS WIRE)--Nov. 16, 1999--

The following is an announcement by the law firm of Weiss & Yourman:

A class action lawsuit class action lawsuit

A lawsuit in which one party or a limited number of parties sue on behalf of a larger group to which the parties belong. For example, investors may bring a class action lawsuit against a brokerage firm that has actively promoted a tax
 against Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois.  ("Abbott" or the "Company")(NYSE NYSE

See: New York Stock Exchange
:ABT ABT About
ABT Abteilung (German: Department)
ABT Abbott Laboratories (stock symbol)
ABT American Ballet Theatre
ABT Associação Brasileira de Telemarketing
ABT Abort
ABT Availability Based Tariff
) and certain individuals associated with the Company was commenced in the United States District Court for the Northern District of Illinois The United States District Court for the Northern District of Illinois is the Federal district court whose jurisdiction comprises the following counties, divided into two divisions:  on behalf of purchasers of Abbott shares. If you purchased Abbott shares between March 17, 1999 and November 2, 1999, please read this notice.

The complaint charges Abbott and certain of its executive officers with violations of the Securities Exchange Act of 1934. The complaint alleges that defendants misrepresented or omitted information regarding the Company and its business operations. The misrepresentation misrepresentation

In law, any false or misleading expression of fact, usually with the intent to deceive or defraud. It most commonly occurs in insurance and real-estate contracts. False advertising may also constitute misrepresentation.
 and/or omission of information caused the Company's stock price to plummet.

This action seeks to recover damages on behalf of defrauded investors who purchased Abbott securities. Plaintiff is represented by Weiss & Yourman, a law firm possessing significant experience and expertise in prosecuting class actions on behalf of defrauded shareholders in federal and state courts throughout the United States. Weiss & Yourman has been appointed by numerous courts to serve as lead counsel in class action lawsuits and in that capacity has recovered hundreds of millions of dollars on behalf of investors.

If you purchased Abbott securities during the period of March 17, 1999 and November 2, 1999, you may move the court no later than December 19, 1999, to serve as a lead plaintiff of the class. In order to serve as a lead plaintiff, you must meet certain legal requirements. You do not need to seek appointment as a lead plaintiff in order to share in any recovery.

If you wish to receive an investor package or if you wish to discuss this action, or have any questions concerning this notice or your rights or interests with respect to this matter, or if you have any information you wish to provide to us, please contact:

David C. Katz, (888) 593-4771 or (212) 682-3025 or via Internet electronic mail at wynyc@aol.com or by writing Weiss & Yourman, The French Building, 551 Fifth Avenue, Suite 1600, New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
 10176.
COPYRIGHT 1999 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1999, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Nov 17, 1999
Words:354
Previous Article:Collectors Universe Announces Financial Results For First Fiscal Quarter.
Next Article:Stull, Stull & Brody Announces Class Periods for Class Action Complaints.
Topics:



Related Articles
Consumer class actions follow suits by generic drug makers against brand-name companies.
GERBER STRAINED WITH CALLS, MAIL OVER LAWSUIT RUMOR : $1,400 REBATE SUPPOSEDLY OFFERED.
SMITHKLINE SUED OVER BILLING.
ABBOTT/EUROPROTEOME TO DEVELOP BREAST CANCER DIAGNOSTIC TESTS.
BRIEFCASE.
US District Court Dismisses Abbott Laboratories' Litigation Against Takeda Pharmaceutical.
Abbott, Wes. Dogby walks alone.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles